LEO 239652   Click here for help

GtoPdb Ligand ID: 12725

Synonyms: compound 40 [PMID: 33054196] | LEO-239652 | LEO239652
PDB Ligand Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: LEO 239652 is an investigational phosphodiesterase 4 (PDE4) soft-drug [1]. It is inactivated in both the blood and liver, as an approach to promote rapid elimination and minimise systemic adverse (gastrointestinal) effects.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 8
Hydrogen bond donors 0
Rotatable bonds 7
Topological polar surface area 89.79
Molecular weight 421.45
XLogP 2.29
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC(C)COC(=O)C1(CC1)C2=NN3C(=CC=C(C3=N2)OC)C4=CC5=C(C=C4)C(=O)OC5
Isomeric SMILES O=C1OCC2=C1C=CC(=C2)C=3N4C(=NC(C5(CC5)C(OCC(C)C)=O)=N4)C(=CC3)OC
InChI InChI=1S/C23H23N3O5/c1-13(2)11-31-22(28)23(8-9-23)21-24-19-18(29-3)7-6-17(26(19)25-21)14-4-5-16-15(10-14)12-30-20(16)27/h4-7,10,13H,8-9,11-12H2,1-3H3
InChI Key LUUUHUYQTLUIDG-UHFFFAOYSA-N
No information available.
Summary of Clinical Use Click here for help
LEO 39652 was advanced to clinical evaluation, however it no longer appears in LEO Pharma's development pipeline.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT01850849 Safety, Tolerability and Pharmacokinetics in AD Subjects and Healthy Subjects of Cutaneous Application of LEO 39652 Cream Phase 1 Interventional LEO Pharma
NCT02219633 Effect of LEO 39652 Cream in Adults With Mild to Moderate Atopic Dermatitis (AD) Phase 1 Interventional LEO Pharma